Current research and treatment for epithelial ovarian cancer A Position Paper from the Helene Harris Memorial Trust

This publication has 29 references indexed in Scilit:

• OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer
  Nature Genetics, 2003
• Genetic analysis of benign ovarian tumors
  International Journal of Cancer, 2003
• A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker
  Biostatistics, 2003
• Chemokine biology in cancer
  Seminars in Immunology, 2002
• Generation of T-Cell Immunity to the HER-2/neu Protein After Active Immunization With HER-2/neu Peptide–Based Vaccines
  Journal of Clinical Oncology, 2002
• Transcriptional profiling reveals that several common fragile-site genes are downregulated in ovarian cancer
  Genes, Chromosomes and Cancer, 2002
• Induction of ovarian cancer by defined multiple genetic changes in a mouse model system
  Cancer Cell, 2002
• Expansion of HER2/neu-Specific T Cells Ex Vivo Following Immunization with a HER2/neu Peptide-Based Vaccine
  Clinical Breast Cancer, 2001
• Combination of Multiple Serum Markers Using an Artificial Neural Network to Improve Specificity in Discriminating Malignant from Benign Pelvic Masses
  Gynecologic Oncology, 1999
• Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium
  International Journal of Cancer, 1992